Atai Life Sciences tumbles on planned stock sale

AtaiBeckley

12/02/2025 21:49

**  U.S.-listed shares of Atai Life Sciences  ATAI.O  down
22% to $1.99 in extended trading on stock sale news
  
    ** German-based depression drug developer  $55 mln stock
offering
  
    ** Co intends to use net offering proceeds for general
purposes, including to advance clinical development of product
candidates and programs
  
    ** Berenberg sole bookrunner
  
    ** Co has , giving it a ~$428 mln market cap
  
    ** ATAI shares finished up 14.3% at $2.55 on Weds. Stock
ended 2024 at $1.33
  

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))